Prime Minister Shri Narendra Modi Launches Nationwide HPV Vaccination Drive for 14-Year-Old Girls from Ajmer, Rajasthan
Prime Minister Shri Narendra Modi Launches Nationwide HPV Vaccination Drive for 14-Year-Old Girls from Ajmer, Rajasthan
Hon’ble Prime Minister Shri Narendra Modi today launched the nationwide Human Papillomavirus (HPV) Vaccination Campaign for 14-year-old girls from Ajmer, Rajasthan, marking a historic milestone in India’s fight against cervical cancer.
Union Health Minister Shri Jagat Prakash Nadda joined the event virtually from Kartavya Bhawan in the presence of Smt. Anupriya Patel, Union MoS for Health and Family Welfare; Dr V K Paul, Member (Health), NITI Aayog and senior officials of the Union Health Ministry. Dr M Srinivas, Director, AIIMS New Delhi; Dr Sandeep Bansal, Director, Safdarjung Hospital and senior officials and doctors from AIIMS New Delhi, Safdarjung Hospital, RML Hospital and Lady Hardinge Medical College were also present on the occasion.
Speaking on the occasion, the Prime Minister described the nationwide HPV vaccination campaign as a pivotal step toward empowering India’s ‘Nari Shakti’ and safeguarding the health of mothers and daughters across the country. “We all know that when a mother falls ill in the family, the house feels scattered. If the mother is healthy, the family remains capable of facing every crisis. With this sentiment the government has run many schemes to provide support to women,” he highlighted.
अजमेर से HPV vaccination अभियान शुरू हुआ है।
ये अभियान देश की नारीशक्ति को सशक्त करने की दिशा में अहम कदम है: PM @narendramodi
Emphasising the Government’s sensitive and mission-driven approach to women’s health and dignity, the Prime Minister referred to transformative interventions such as large-scale toilet construction under sanitation initiatives, provision of affordable sanitary pads and the Pradhan Mantri Ujjwala Yojana, which has ensured clean cooking fuel for millions of households.
He also spoke about the safe motherhood scheme under which ₹5,000 is directly transferred into the bank accounts of expectant mothers to support nutritious food during pregnancy. The Prime Minister underlined that these initiatives reflect a shift from a culture of neglect to one rooted in care, dignity and sensitivity towards women’s health and well-being.
The national launch event in Ajmer witnessed virtual participation from all States and Union Territories. Hon’ble Governors, Hon’ble Chief Ministers, Hon’ble Deputy Chief Ministers, Hon’ble Administrator, Hon’ble State Health Ministers, Hon’ble Education Minister, along with Additional Chief Secretaries, Principal Secretaries, Secretaries and senior health officials joined from their respective State/UT headquarters.
Cervical cancer remains a significant public health concern globally and in India. It is the second most common cancer among women in India, with over 1 lakh 20 thousand new cases and nearly 80 thousand deaths reported annually as per the WHO GLOBOCAN report 2022. Persistent infection with high-risk Human Papillomavirus (HPV) types, particularly types 16 and 18 – has been established as the primary cause of cervical cancer.
The nationwide HPV vaccination campaign aims to prevent cervical cancer by protecting girls before potential exposure to HPV infection. The vaccine is safe, effective and provides long-lasting protection against HPV strains responsible for the majority of cervical cancer cases.
HPV vaccination has been validated and recommended by global and national expert bodies including the World Health Organization (WHO) and India’s National Technical Advisory Group on Immunization (NTAGI).
Globally 160 out of 194 countries have introduced HPV vaccine under their National Immunization Programmes. 90 countries have adopted a single-dose schedule, including majority of Southeast Asian countries. 80 countries are using Gardasil-4 vaccine in their National Immunization Programme. Out of these, 61 countries are implementing a single-dose schedule of Gardasil-4.
HPV vaccines are 93–100% effective in preventing cervical cancer caused by vaccine-covered HPV types. Evidence also shows a strong herd effect – high vaccination coverage reduces circulation of HPV strains, thereby providing indirect protection even to unvaccinated individuals.
India’s national programme uses Gardasil-4 (Quadrivalent: HPV types 6, 11, 16, 18) in a single-dose schedule, aligned with global scientific evidence and WHO recommendations.
Target Population and Coverage:
The campaign will cover girls aged 14 years (those who have completed 14 years but have not yet completed 15 years). As per Registrar General of India (RGI) 2021 estimates, the annual cohort of 14-year-old girls is approximately 1.2 crore, who are expected to benefit from this initiative each year.
Operational Plan of the HPV Vaccination Campaign:
The introduction of HPV vaccination in India has been meticulously planned with detailed attention to safety, logistics and monitoring.
Key Features:
Vaccination Duration: 3 months (90 days) in campaign mode.
After completion of the campaign phase, HPV vaccine will be available on routine immunization session days.
Session Sites: Only Government Health Facilities like Ayushman Arogya Mandir (AAM) – Primary Health Centres (PHCs), Community Health Centres (CHCs), Sub-District Hospitals (SDHs), District Hospitals (DHs), Government Medical Colleges and Hospitals (GMCHs)
Dose & Administration: Single dose (0.5 ml) Intramuscular (IM) injection in the left upper arm
Vaccination is voluntary, free of cost and will be administered only after parental/guardian consent.
Beneficiaries may pre-register and schedule appointments on the U-WIN digital platform, or opt for walk-in vaccination at designated government health facilities. Parental/guardian consent is mandatory and will be recorded digitally on U-WIN. In areas without internet connectivity, consent may be obtained in hard copy as per prescribed format.
The U-WIN platform will be used for session planning, registration, recording and reporting, while the e-VIN portal will manage vaccine stocks and logistics.
Extensive preparatory activities, including nationwide capacity-building exercises covering all technical and operational aspects, have been undertaken. Detailed guidelines have been shared with all States and Union Territories to ensure seamless implementation.
The programme follows strict medical guidelines. Vaccination will be deferred or avoided in the following cases:
For girls who have already received any HPV vaccine (Gardasil, Gardasil-9, Cervarix, or Cervavac), their vaccination status will be updated on the U-WIN portal.
All vaccination sessions are conducted under supervision of trained Medical Officers, with functional Cold Chain Points (CCPs) and linkage to 24×7 government health facilities for management of any rare Adverse Events Following Immunization (AEFI).
Following the Prime Minister’s national launch, HPV vaccination campaign launches were held across all States and Union Territories through local events.
The nationwide HPV vaccination campaign represents a transformative step in India’s preventive healthcare strategy and reflects delivery-oriented governance rooted in scientific evidence and implementation readiness.
The Union Ministry of Health and Family Welfare urges parents and guardians to ensure that their 14-year-old daughters receive the HPV vaccine during the campaign period. HPV vaccination is a powerful preventive intervention that can save lives and secure a healthier, cancer-free future for India’s daughters.
***